# Step 2: Hazard Identification (FMEA)

## MANDATORY EXECUTION RULES (READ FIRST):

- ğŸ›‘ NEVER assume a hazard is too unlikely to document
- âœ… Tout danger identifiable doit Ãªtre analysÃ©
- ğŸ“‹ SYSTEMATIC analysis â€” no shortcuts
- ğŸ’¬ Think like an attacker, protect like a guardian
- âœ… YOU MUST ALWAYS SPEAK OUTPUT in your Agent communication style with the config `{communication_language}`

## EXECUTION PROTOCOLS:

- ğŸ¯ Analyze each software function for failure modes
- ğŸ“– Consider all harm pathways
- ğŸ’¾ Document all identified hazards
- ğŸš« FORBIDDEN to dismiss hazards without documented rationale

## YOUR TASK:

Systematically identify all hazards and failure modes using FMEA methodology.

## HAZARD IDENTIFICATION SEQUENCE:

### 1. FMEA Structure Introduction

"**Analyse FMEA (Failure Mode and Effects Analysis)**

Pour chaque fonction/module du logiciel, nous analyserons :

| Ã‰lÃ©ment | Description |
|---------|-------------|
| **Function** | Fonction logicielle analysÃ©e |
| **Failure Mode** | Comment la fonction peut Ã©chouer |
| **Cause** | Cause probable de la dÃ©faillance |
| **Effect** | Effet de la dÃ©faillance sur le systÃ¨me |
| **Harm** | ConsÃ©quence pour le patient/utilisateur |
| **Severity** | GravitÃ© du harm (1-5) |
| **Probability** | ProbabilitÃ© d'occurrence (1-5) |
| **Detectability** | CapacitÃ© Ã  dÃ©tecter avant harm |

**Ã‰chelle de SÃ©vÃ©ritÃ© (S):**
| Score | Niveau | DÃ©finition |
|-------|--------|------------|
| 1 | NÃ©gligeable | Aucun harm ou inconfort mineur |
| 2 | Mineur | Inconfort temporaire, pas d'intervention |
| 3 | SÃ©rieux | Intervention mÃ©dicale nÃ©cessaire |
| 4 | Critique | Blessure permanente possible |
| 5 | Catastrophique | DÃ©cÃ¨s ou blessure irrÃ©versible |

**Ã‰chelle de ProbabilitÃ© (P):**
| Score | Niveau | DÃ©finition |
|-------|--------|------------|
| 1 | Improbable | < 1/10,000 utilisations |
| 2 | Rare | 1/1,000 - 1/10,000 |
| 3 | Occasionnel | 1/100 - 1/1,000 |
| 4 | Probable | 1/10 - 1/100 |
| 5 | FrÃ©quent | > 1/10 utilisations |"

### 2. Systematic Function Analysis

For each major function identified in step-01:

"**Analyse de la fonction : {function_name}**

**Description:** {function_description}

**Modes de dÃ©faillance possibles:**

1. **Output incorrect (faux positif/nÃ©gatif)**
   - Cause possible : {cause}
   - Effet sur systÃ¨me : {effect}
   - Harm potentiel : {harm}

2. **IndisponibilitÃ©/timeout**
   - Cause possible : {cause}
   - Effet sur systÃ¨me : {effect}
   - Harm potentiel : {harm}

3. **DonnÃ©es corrompues**
   - Cause possible : {cause}
   - Effet sur systÃ¨me : {effect}
   - Harm potentiel : {harm}

4. **Performance dÃ©gradÃ©e**
   - Cause possible : {cause}
   - Effet sur systÃ¨me : {effect}
   - Harm potentiel : {harm}

Identifiez-vous d'autres modes de dÃ©faillance pour cette fonction ?"

### 3. Harm Categories for SaMD

Guide the analysis with SaMD-specific categories:

"**CatÃ©gories de harm spÃ©cifiques aux SaMD:**

**Harms cliniques directs:**
- [ ] Diagnostic incorrect menant Ã  traitement inappropriÃ©
- [ ] Retard de diagnostic d'une condition grave
- [ ] Surdosage ou sous-dosage de traitement
- [ ] Intervention inappropriÃ©e basÃ©e sur recommandation

**Harms cliniques indirects:**
- [ ] Fausse rÃ©assurance retardant consultation
- [ ] AnxiÃ©tÃ© due Ã  faux positif
- [ ] Perte de confiance dans le systÃ¨me de soins

**Harms liÃ©s aux donnÃ©es:**
- [ ] Violation de confidentialitÃ© (RGPD/HIPAA)
- [ ] DonnÃ©es patient accessibles Ã  non-autorisÃ©s
- [ ] Perte de donnÃ©es cliniques critiques

**Harms liÃ©s Ã  l'utilisation:**
- [ ] Erreur d'utilisation due Ã  interface confuse
- [ ] Utilisation hors indication (off-label)
- [ ] DÃ©pendance excessive au logiciel

**Harms cybersÃ©curitÃ©:**
- [ ] Manipulation des rÃ©sultats par attaquant
- [ ] Ransomware affectant disponibilitÃ©
- [ ] Exfiltration de donnÃ©es patient

Quelles catÃ©gories sont applicables Ã  **{project_name}** ?"

### 4. Document Hazards in Risk Register

For each identified hazard, create entry:

"**Nouveau risque identifiÃ©:**

| Champ | Valeur |
|-------|--------|
| RISK ID | RISK-{module}-{nnn} |
| Module/Function | {function} |
| Hazard | {hazard_description} |
| Failure Mode | {failure_mode} |
| Cause | {cause} |
| Harm | {harm_description} |
| Severity (S) | {1-5} |
| Probability (P) | {1-5} |
| RPN | {S Ã— P} |
| Level | {Acceptable/ALARP/Unacceptable} |
| Control | {TBD - step 3} |

**AcceptabilitÃ©:**
- RPN â‰¤ 6 : âœ… Acceptable
- RPN 7-12 : âš ï¸ ALARP (As Low As Reasonably Practicable)
- RPN > 12 : âŒ Inacceptable â€” contrÃ´le requis

Ce risque est classÃ© **{level}**."

### 5. AI/ML Specific Hazards (if applicable)

If the product includes AI/ML:

"**Risques spÃ©cifiques AI/ML:**

**Performance degradation:**
- [ ] Distribution shift (donnÃ©es rÃ©elles â‰  donnÃ©es d'entraÃ®nement)
- [ ] Concept drift (Ã©volution dans le temps)
- [ ] Out-of-distribution (OOD) inputs
- [ ] Adversarial inputs (manipulation intentionnelle)

**Bias and fairness:**
- [ ] Biais dÃ©mographique (Ã¢ge, genre, ethnicitÃ©)
- [ ] Biais socio-Ã©conomique
- [ ] Sous-performance sur populations sous-reprÃ©sentÃ©es

**Explainability:**
- [ ] DÃ©cision non explicable au clinicien
- [ ] IncapacitÃ© Ã  identifier les inputs critiques
- [ ] Black box inappropriÃ© pour contexte clinique

**Training/updating:**
- [ ] Contamination des donnÃ©es d'entraÃ®nement
- [ ] Overfitting sur donnÃ©es spÃ©cifiques
- [ ] Model update introduisant rÃ©gression

RÃ©fÃ©rence: FDA AI/ML Action Plan, `_bmad/bmmd/checklists/ai-ml-validation-checklist.md`"

### 6. Compile Hazard List

Present summary:

"**RÃ©capitulatif des dangers identifiÃ©s pour {project_name}:**

| RISK ID | Hazard | Harm | S | P | RPN | Level |
|---------|--------|------|---|---|-----|-------|
| RISK-001 | {hazard} | {harm} | {s} | {p} | {rpn} | {level} |
| RISK-002 | {hazard} | {harm} | {s} | {p} | {rpn} | {level} |
| ... | ... | ... | ... | ... | ... | ... |

**Statistiques:**
- Total risques identifiÃ©s : {count}
- Inacceptables (RPN > 12) : {count} âŒ
- ALARP (RPN 7-12) : {count} âš ï¸
- Acceptables (RPN â‰¤ 6) : {count} âœ…

**[C] Continuer** â€” ProcÃ©der Ã  la dÃ©finition des contrÃ´les
**[A] Ajouter** â€” Identifier d'autres dangers
**[R] RÃ©viser** â€” Modifier les Ã©valuations S/P"

## SUCCESS METRICS:

âœ… All major functions analyzed for failure modes
âœ… SaMD-specific harm categories considered
âœ… AI/ML risks addressed if applicable
âœ… Each hazard documented with S, P, RPN
âœ… Risk Register updated

## FAILURE MODES:

âŒ Missing obvious failure modes
âŒ Not considering indirect harms
âŒ Underestimating severity or probability
âŒ Not documenting AI/ML specific risks

## NEXT STEP:

After user selects [C] to continue, load `./step-03-risk-control.md`.

Remember: Do NOT proceed until user explicitly selects [C]!
